Viemed Healthcare Q3 revenue rises, but slightly misses estimates
Overview
US home-based healthcare provider's Q3 revenue grew 12% yr/yr, slightly missing analyst expectations
Company raised low end of full-year revenue guidance and narrowed adjusted EBITDA outlook
Outlook
Viemed expects 2026 revenue between $316 mln and $320 mln
Company narrows 2026 Adjusted EBITDA outlook to $64 mln-$66 mln
Net capital expenditures for 2026 now seen at 8.0%-9.0% of revenue
Result Drivers
VENTILATOR PATIENT VOLUME - Co said higher average patient volumes drove growth in ventilator rental revenue
PAP AND SLEEP RESUPPLY - Co reported strong growth in PAP therapy and sleep resupply patient counts
OPERATING LEVERAGE - Co attributed improved profitability to operating leverage and efficiency gains from earlier investments
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Slight Miss* | $80.67 mln | $80.78 mln (3 Analysts) |
Q3 Net Income Attributable to Shareholders | $4.64 mln | ||
Q3 Gross Profit | $46.19 mln | ||
Q3 Income from Operations | $6.96 mln |
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Viemed Healthcare Inc is $12.50, about 32.2% above its November 3 closing price of $9.46
The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 21 three months ago
Reuters Recommended Reads
Nov 3 - Addus HomeCare Q3 adjusted EPS beats estimates; to acquire AccentCare personal care division
Nov 3 - Senior care provider InnovAge's Q1 revenue beats as participants increase
Nov 3 - AdaptHealth posts Q3 loss due to goodwill impairment charge
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)